Dugad Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.15 Cr
as on 21-12-2024
- Satisfied Charges ₹ 5.50 M
as on 21-12-2024
- Revenue 6.18%
(FY 2022)
- Profit 20.47%
(FY 2022)
- Ebitda 920.08%
(FY 2022)
- Net Worth 6.55%
(FY 2022)
- Total Assets 6.44%
(FY 2022)
About Dugad Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.15 Cr. The company has closed loans amounting to ₹5.50 M, as per Ministry of Corporate Affairs (MCA) records.
Milind Dugad and Avinash Kothari serve as directors at the Company.
- CIN/LLPIN
U85110PN2003PTC017784
- Company No.
017784
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dugad Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milind Dugad  | Director | 17-Mar-2003 | Current |
| Avinash Kothari | Director | 17-Mar-2006 | Current |
Financial Performance of Dugad Hospital.
Dugad Hospital Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.18% increase. The company also saw a substantial improvement in profitability, with a 20.47% increase in profit. The company's net worth moved up by a moderate rise of 6.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dugad Hospital?
In 2021, Dugad Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹11.54 M
₹5.50 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Oct 2006 | State Bank Of India | ₹6.54 M | Open |
| 31 Jul 2006 | State Bank Of India | ₹5.00 M | Open |
| 18 Oct 2004 | Kotak Mahindra Bank Limited | ₹5.50 M | Satisfied |
How Many Employees Work at Dugad Hospital?
Dugad Hospital has a workforce of 28 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dugad Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dugad Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.